Zdrowie i gospodarka · 05/11/2020

FDA to Host Public Workshop on Opioid Analgesics Risk Evaluation and Mitigation Strategy Education Program

The Food and Drug Administration (FDA) is hosting a public workshop to gather scientific input on the effectiveness of its Opioid Analgesics Risk Evaluation and Mitigation Strategy (OA REMS) education program, which aims to improve prescribing behaviors and patient outcomes. The workshop will explore ways to assess the program's impact.